Log in to your Inderes Free account to see all free content on this page.
Klaria Pharma Holding
0.78 SEK
-5.54 %
Less than 1K followers
KLAR
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Klaria Pharma Holding
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 3.97 | 5.67 | 5.64 | 1.13 | 0.45 | 0.33 | 0.67 |
| Shares | 34.1 | 56.7 | 56.7 | 80.4 | 109.3 | 148.5 | 246.0 |
| Market cap | 135.2 | 321.2 | 319.7 | 90.9 | 49.2 | 48.5 | 163.8 |
| Enterprise value | 132.3 | 290.0 | 294.2 | - | - | - | - |
| EV/S | 31.3 | - | - | - | - | - | - |
| EV/EBITDA | neg. | neg. | neg. | - | - | - | - |
| EV/EBIT | neg. | neg. | neg. | - | - | - | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | 1.65 | 2.93 | 4.61 | 1.20 | 1.20 | 14.65 | -42.23 |
| P/S | 32.0 | - | - | 15.5 | - | 21.6 | 18.2 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 80.7 % | 82.8 % | 58.7 % | 63.3 % | 56.3 % | 5.8 % | -9.5 % |
| Gearing ratio | - | - | - | - | - | - | - |
Login required
This content is only available for logged in users